Management of Extraglandular Manifestations of Primary Sjogren's Syndrome

被引:5
|
作者
Wu, Jason J. [1 ,2 ]
Carsons, Steven E. [1 ,3 ]
机构
[1] Winthrop Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Mineola, NY 11501 USA
[2] Nassau Cty Med Ctr, E Meadow, NY 11554 USA
[3] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
关键词
Sjogren's syndrome; Joint pain; NSAIDs; Anti-TNF; POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS; FATIGUE; INVOLVEMENT; RITUXIMAB; VASCULITIS; EFFICACY;
D O I
10.1016/j.coms.2013.09.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Primary Sjogren's syndrome can have multiple extra-glandular manifestations ranging from mild to severe. Treatment for extra-glandular manifestations is organ specific and therapies are targeted based on the primary organs involved. Preferred treatment options used for extra-glandular manifestations of Sjogren's syndrome are usually extrapolated from the physician's experience in treating similar manifestations in other autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematous. The lack of immunomodulating disease modifying drugs in Sjogren's syndrome can be frustrating for patients dealing with extra-glandular manifestations, however recent advances in the field has made the future look promising for new therapeutic options.
引用
收藏
页码:101 / +
页数:10
相关论文
共 50 条
  • [31] Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sjogren's syndrome
    Pertovaara, Marja
    Bootorabi, Fatemeh
    Kuuslahti, Marianne
    Pasternack, Amos
    Parkkila, Seppo
    RHEUMATOLOGY, 2011, 50 (08) : 1453 - 1457
  • [32] SER recommendations on the use of biological drugs in primary Sjogren's syndrome
    Andreu Sanchez, Jose Luis
    Fernandez Castro, Monica
    del Campo Fontecha, Petra Diaz
    Corominas, Hector
    Narvaez Garcia, Francisco Javier
    Gomez de Salazar, Jose Rosas
    Rua-Figueroa, Inigo
    Abad Hernandez, Miguel Angel
    Alvarez Rivas, Maria Noelia
    del Pino Montes, Javier
    Francisco Hernandez, Felix Manuel
    Gantes Pedraza, Maria Angeles
    Greco Merino, Martin Gerardo
    Vanesa Hernandez, Maria
    Navarro Compan, Maria Victoria
    Paz Solarte, Juan Alberto
    Romero Bueno, Fredeswinda, I
    Park, Hye Sang
    Sivera Mascaro, Francisca
    REUMATOLOGIA CLINICA, 2019, 15 (06): : 315 - 326
  • [33] Frequency of systemic manifestations in patients with primary Sjogren's syndrome in Argentina
    Zazzetti, Federico
    Adolfo Rivero, Mariano
    Duartes Noe, Damian Elvio
    Gallacher, Alberto
    Schiel, Amalia
    Claudia Khoury, Marina
    Armando Laborde, Hugo
    Carlos Barreira, Juan
    REUMATOLOGIA CLINICA, 2010, 6 (06): : 299 - 302
  • [34] Oral manifestations of Sjogren's syndrome
    Mathews, S. A.
    Kurien, B. T.
    Scofield, R. H.
    JOURNAL OF DENTAL RESEARCH, 2008, 87 (04) : 308 - 318
  • [35] Novel Therapeutic Strategies in Primary Sjogren's Syndrome
    Alunno, Alessia
    Carubbi, Francesco
    Bistoni, Onelia
    Bartoloni, Elena
    Valentini, Valentina
    Gerli, Roberto
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (09): : 576 - 580
  • [36] Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjogren's syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjogren's Syndrome Endocrinopathy) and ROSE II trials
    Tsuboi, Hiroto
    Toko, Hirofumi
    Honda, Fumika
    Abe, Saori
    Takahashi, Hiroyuki
    Yagishita, Mizuki
    Hagiwara, Shinya
    Ohyama, Ayako
    Kondo, Yuya
    Nakano, Kazuhisa
    Tanaka, Yoshiya
    Shimizu, Toshimasa
    Nakamura, Hideki
    Kawakami, Atsushi
    Fujieda, Yuichiro
    Atsumi, Tatsuya
    Suzuki, Yasunori
    Kawano, Mitsuhiro
    Nishina, Naoshi
    Kaneko, Yuko
    Takeuchi, Tsutomu
    Kobayashi, Hitomi
    Takei, Masami
    Ogasawara, Michihiro
    Tamura, Naoto
    Takasaki, Yoshinari
    Yokota, Kazuhiro
    Akiyama, Yuji
    Mimura, Toshihide
    Murakami, Kosaku
    Mimori, Tsuneyo
    Ohshima, Shiro
    Azuma, Naoto
    Sano, Hajime
    Nishiyama, Susumu
    Matsumoto, Isao
    Sumida, Takayuki
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 160 - 168
  • [37] Pain in primary Sjogren's syndrome
    Vitali, Claudio
    Del Papa, Nicoletta
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2015, 29 (01): : 63 - 70
  • [38] Management of Xerostomia and Other Complications of Sjogren's Syndrome
    Pinto, Andres
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2014, 26 (01) : 63 - +
  • [39] Multimodal Evoked Potentials in Primary Sjogren's Syndrome Without Neurological Manifestations
    Gokcay, Figen
    Celebisoy, Nese
    Gokcay, Ahmet
    Oder, Gonca
    Kabasakal, Yasemin
    Aksu, Kenan
    Kose, Timur
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2009, 26 (04): : 390 - 395
  • [40] The influence of age on disease manifestations and serological characteristics in primary Sjogren's syndrome
    Haga, HJ
    Jonsson, R
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1999, 28 (04) : 227 - 232